A

Allina Health cuts 30-day readmissions by 10.3% and saves $4.2M annually with predictive risk scoring

“Allina Health cuts 30-day readmissions by 10.3% and saves $4.2M annually with predictive risk scoring” documents a Clinical Decision Support deployment in Hospital & Health System at Allina Health. sranalytics.io reports annual savings: $4.2M; this directory has not independently verified that result.

Maintained by Peter Korpak, Founder & Chief AnalystHow evidence is checked

Evidence at a glance

Evidence status:
Automated evidence gate passed
Deployment timeframe:
Not reported by source
Reported outcome metrics:
3 cited below
Directory entry published:
Source link checked:

The source-link check confirms reachability, not independent re-verification of every claim.

$4.2MAnnual Savings
10.3%30-Day Readmission Reduction
472%3-Year ROI

Source-reported figures — cited source: sranalytics.io

The Challenge

Allina Health's 12-hospital Minnesota system faced millions in costs and Medicare penalties from preventable 30-day readmissions. Their reactive discharge model lacked the ability to identify high-risk patients before they left the hospital, leaving care coordinators without actionable signals at the point of discharge.

The Solution

Implemented predictive risk scoring via Health Catalyst across all 12 hospitals in 2018, combining 47 variables — including prior admissions, medication adherence, and social determinants — into a single readmission risk score calculated at discharge. Critically, they redesigned discharge workflows around the score rather than treating it as a separate dashboard.

Results

Achieved a 10.3% reduction in 30-day readmissions, generating $4.2 million in annual savings from avoided penalties and costs. The $890,000 implementation investment yielded a 472% ROI over three years.

Key Takeaways

  • Workflow redesign is as important as the technology — embedding the risk score into discharge processes drove adoption far more than the model accuracy alone.
  • Combining social determinants with clinical variables substantially improves predictive power.
  • Framing the tool as a care process redesign initiative rather than an analytics project was key to clinical buy-in.

Share:

Details

Company Size
Enterprise
Evidence status
Automated evidence gate passed
Deployment timeframe
Not reported by source
Directory entry published
Source link checked

Cited source

sranalytics.io

Have a similar implementation?

Share your customer's AI results and link it to your vendor profile.

Submit a case study →